COST-effectiveness of salmeterol/fluticasone propionate combination (Advair®) in uncontrolled asthma in Canada. Ismaila, A. S, Risebrough, N., Li, C., Corriveau, D., Hawkins, N., FitzGerald, J M., & Su, Z. Respiratory medicine, 108(9):1292–1302, 2014.
bibtex   
@article{ismaila_cost-effectiveness_2014-1,
	title = {{COST}-effectiveness of salmeterol/fluticasone propionate combination ({Advair}®) in uncontrolled asthma in {Canada}},
	volume = {108},
	number = {9},
	journal = {Respiratory medicine},
	author = {Ismaila, Afisi S and Risebrough, Nancy and Li, Chunmei and Corriveau, Diane and Hawkins, Neil and FitzGerald, J Mark and Su, Zhen},
	year = {2014},
	keywords = {Asthma, Canada, Cost-effectiveness, Quality adjusted life years, Salmeterol/fluticasone propionate},
	pages = {1292--1302},
}

Downloads: 0